Narges Vasei1, Azita Shishegar2, Forouzan Ghalkhani1, Mohammad Darvishi3. 1. Department of Surgery, Besat Hospital, AJA University of Medical Sciences, Tehran, Iran. 2. Department of Surgery, Besat Hospital, AJA University of Medical Sciences, Tehran, Iran. dr_shishegar@armyums.ac.ir. 3. Infectious Diseases and Tropical Medicine Research Center (IDTMRC), Department of Aerospace and Subaquatic Medicine, AJA University of Medical Sciences, Tehran, Iran.
Correction to: Lipids Health Dis (2019) 18:139https://doi.org/10.1186/s12944-019-1078-4Following publication of the original article [1], the authors reported an incorrect reference found in Figs. 1, 2, 2 and 4 legends.The corrected figure legends are shown below.Fig. 1 Different levels of fatnecrosis (Adapted with permission from Taboada et al. [3]). a Primary level of fatnecrosis indicates fragments of adipose tissue. b Primary level of fatnecrosis indicates individual adipocytes. c Medium level of fatnecrosis indicates infiltration by histiocytes. d Medium level of fatnecrosis indicates conglomeration of RBCs referred to as “myospherulosis”. e Late stage of fatnecrosis indicates single multinucleated giant cell. f Late stage of fatnecrosis indicates calcifications (are common in late stage of fatnecrosis). g Late stage of fatnecrosis indicates macrophages containing hemosiderin. h Late stage of fatnecrosis indicates calcificationsFig. 2 Craniocaudal mammograms and right breast mediolateral oblique. a and b) show round masses with radiolucent centers at the site of palpable finding. c) Ultrasound of the right breast at site of palpable finding demonstrate two hypoechoic round masses with central echogenicity with associated posterior acoustic shadowing (Adapted with permission from Kerridge et al. [19])Fig. 3 Craniocaudal projections and right breast mediolateral oblique. a and b) show a radiolucent lobular mass at site of palpable mass (arrow). c) Targeted ultrasound at site of palpable mass demonstrates a lobular heterogeneous hypoechoic mass with posterior acoustic shadowing. d) Axial T1-weighted fat saturation after gadolinium. e) T2-weighted nonfat saturation, and f) subtraction images that indicate a mass at 11 o’clock in the right breast anteriorly that follows fat signal on all sequences with thin rim enhancement (Adapted with permission from Kerridge et al. [19])Fig. 4 A patient who shows a mass in the left breast which follows fat signal on all sequences (arrow). a) Axial T1-weighted nonfat saturation, b) T2-weighted nonfat saturation, c) T1-weighted fat saturation after gadolinium and d) subtraction images (Adapted with permission from Kerridge et al. [19])